Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Various Advanced Cancer × Cisplatin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 215 Lung Neoplasms 55 Head and Neck Neoplasms 50 Stomach Neoplasms 49 Neoplasms 48 Squamous Cell Carcinoma of Head and Neck 40 Parkinson Disease 4, Autosomal Dominant Lewy Body 40 Neoplasm Metastasis 34 Small Cell Lung Carcinoma 33 Esophageal Neoplasms 25 Urinary Bladder Neoplasms 24 Colorectal Neoplasms 23 Cholangiocarcinoma 23 Biliary Tract Neoplasms 23 Uterine Cervical Neoplasms 22 Carcinoma 20 Ovarian Neoplasms 19 Carcinoma, Squamous Cell 17 Recurrence 15 Esophageal Squamous Cell Carcinoma 14 Carcinoma, Transitional Cell 14 Mesothelioma, Malignant 12 Melanoma 12 Non-Squamous Non-Small Cell Lung Cancer 11 Breast Neoplasms 11 Adenocarcinoma 11 Nasopharyngeal Carcinoma 10 Mesothelioma 10 Gallbladder Neoplasms 10 Bile Duct Neoplasms 10

Interventions

Nivolumab 4 Ipilimumab 2 Fluorouracil 1 Cisplatin 1 BMS-986115 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03143153 2026-02-17

CheckMate 648

Bristol-Myers Squibb

Phase 3 Completed

970 enrolled 15 charts 1 FDA

Various Advanced Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡